# Nano-crystalline Megestrol Acetate for Chemotherapy-induced Nausea and Vomiting

> **NCT07246070** · PHASE2 · NOT_YET_RECRUITING · sponsor: **AIPING ZHOU** · enrollment: 127 (estimated)

## Conditions studied

- Chemotherapy-Induced Nausea and Vomiting (CINV)

## Interventions

- **DRUG:** nanocrystalline megestrol acetate combined with ondansetron
- **DRUG:** dexamethasone combined with ondansetron

## Key facts

- **NCT ID:** NCT07246070
- **Lead sponsor:** AIPING ZHOU
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2026-08
- **Final completion:** 2026-12
- **Target enrollment:** 127 (ESTIMATED)
- **Last updated:** 2025-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07246070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07246070, "Nano-crystalline Megestrol Acetate for Chemotherapy-induced Nausea and Vomiting". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07246070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*